A multicentric, phase III clinical trial to assess the immunogenicity and reactogenicity of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed administered to healthy infants at 6, 10 and 14 weeks of age.
Phase of Trial: Phase III
Latest Information Update: 31 Aug 2016
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- 19 Apr 2012 New trial record